rs752729755
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004260.4(RECQL4):โc.2492_2493delATโ(p.His831fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000606 in 1,568,660 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (โ โ ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: ๐ 0.000033 ( 0 hom., cov: 34)
Exomes ๐: 0.000064 ( 0 hom. )
Consequence
RECQL4
NM_004260.4 frameshift
NM_004260.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.40
Genes affected
RECQL4 (HGNC:9949): (RecQ like helicase 4) The protein encoded by this gene is a DNA helicase that belongs to the RecQ helicase family. DNA helicases unwind double-stranded DNA into single-stranded DNAs and may modulate chromosome segregation. This gene is predominantly expressed in thymus and testis. Mutations in this gene are associated with Rothmund-Thomson, RAPADILINO and Baller-Gerold syndromes. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 8-144513108-CAT-C is Pathogenic according to our data. Variant chr8-144513108-CAT-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 6064.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-144513108-CAT-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RECQL4 | NM_004260.4 | c.2492_2493delAT | p.His831fs | frameshift_variant | 15/21 | ENST00000617875.6 | NP_004251.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RECQL4 | ENST00000617875.6 | c.2492_2493delAT | p.His831fs | frameshift_variant | 15/21 | 1 | NM_004260.4 | ENSP00000482313.2 | ||
RECQL4 | ENST00000621189.4 | c.1421_1422delAT | p.His474fs | frameshift_variant | 14/20 | 1 | ENSP00000483145.1 | |||
RECQL4 | ENST00000534626.6 | c.662_663delAT | p.His221fs | frameshift_variant | 6/8 | 5 | ENSP00000477457.1 | |||
ENSG00000265393 | ENST00000580385.1 | n.271+272_271+273delAT | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000330 AC: 5AN: 151338Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
5
AN:
151338
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000769 AC: 16AN: 208088Hom.: 0 AF XY: 0.0000621 AC XY: 7AN XY: 112668
GnomAD3 exomes
AF:
AC:
16
AN:
208088
Hom.:
AF XY:
AC XY:
7
AN XY:
112668
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000635 AC: 90AN: 1417210Hom.: 0 AF XY: 0.0000544 AC XY: 38AN XY: 699038
GnomAD4 exome
AF:
AC:
90
AN:
1417210
Hom.:
AF XY:
AC XY:
38
AN XY:
699038
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000330 AC: 5AN: 151450Hom.: 0 Cov.: 34 AF XY: 0.0000270 AC XY: 2AN XY: 74000
GnomAD4 genome
AF:
AC:
5
AN:
151450
Hom.:
Cov.:
34
AF XY:
AC XY:
2
AN XY:
74000
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Baller-Gerold syndrome Pathogenic:2Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | This sequence change creates a premature translational stop signal (p.His831Argfs*52) in the RECQL4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RECQL4 are known to be pathogenic (PMID: 12734318, 12952869). This variant is present in population databases (rs752729755, gnomAD 0.03%). This premature translational stop signal has been observed in individual(s) with clinical features of RECQL4-related conditions (PMID: 10319867, 19291770, 24518840, 28486640). ClinVar contains an entry for this variant (Variation ID: 6064). For these reasons, this variant has been classified as Pathogenic. - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | DASA | Aug 10, 2022 | The c.2492_2493del;p.(His831Argfs*52) is a null frameshift variant (NMD) in the RECQL4 gene and predicts alteration of the nonsense-mediate decay - NMD is present in a relevant exon to the transcript - PVS1.This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant(ClinVar ID: 6064; OMIM: 603780.0003; PMID: 28486640; 24518840; 19291770) - PS4. The variant is present at low allele frequencies population databases (rs752729755 โ gnomAD 0.0003304%; ABraOM no frequency - https://abraom.ib.usp.br/) -PM2_supporting.The p.(His831Argfs*52) was detected in trans with a pathogenic variant (PMID: 28486640; 24518840; 19291770) - PM3_strong. The variant co-segregated with disease in multiple affected family members (PMID: 24518840) - PP1. In summary, the currently available evidence indicates that the variant is pathogenic. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 18, 2023 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 10319867, 24518840, 29478780, 29462647, 19291770, 31604778, 29625052, 31589614, 33294214, 32482547, 33077847, 28486640) - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 09, 2024 | The c.2492_2493delAT (p.H831Rfs*52) alteration, located in exon 15 (coding exon 15) of the RECQL4 gene, consists of a deletion of 2 nucleotides from position 2492 to 2493, causing a translational frameshift with a predicted alternate stop codon after 52 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, the c.2493_2494delAT allele has an overall frequency of 0.007% (17/239426) total alleles studied. The highest observed frequency was 0.0128% (1/23520) of South Asian alleles. This variant has been identified in conjunction with other RECQL4 variants in individuals with features consistent with RECQL4-related disorder; in at least one instance, the variants were identified in trans (Debeljak, 2009; Colombo, 2014; Zhang, 2020; Gutiérrez-Jimeno, 2020). Based on the available evidence, this alteration is classified as pathogenic. - |
Rapadilino syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Jun 26, 2019 | This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PS1,PM2. - |
Rothmund-Thomson syndrome type 2 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 15, 1998 | - - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | curation | Sema4, Sema4 | Nov 01, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at